efficient esterification of oxidized l-glutathione and other small peptides Advances in Peptidomimetics for Next-Generation Therapeutics: Strategies, Modifications, Applications Bacteria on 2-keto-L-gulonic Acid Production

Sperber: nothing to disclose

Retatrutide achieved up to 24.2% body weight reduction in 48 weeks in Phase 2, and the recently completed Phase 3 TRIUMPH-4 trial pushed that number to an unprecedented 28.7% at 68 weeks

Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimers disease pathology in transgenic mouse model

This dual-receptor pharmacology, GH release through GHSR1a and cardioprotection through CD36, gives GHRP-6 a therapeutic profile that newer, more selective secretagogues like ipamorelin do not possess

The exact temperature thresholds for every semaglutide formulation Not all semaglutide is created equal when it comes to heat tolerance

This process facilitated the generation of context-specific models for each cell or gene expression dataset